EcoDrugPlus

Somatostatin Receptor 3

Ensembl ID : ENSODEG00000020157
Gene Symbol: SSTR3
3 Cross references
249 Possible Orthologues:

Somatostatin Receptor 5

Ensembl ID : ENSODEG00000020248
Gene Symbol: SSTR5
3 Cross references
256 Possible Orthologues:

Sphingosine Kinase 2

Ensembl ID : ENSODEG00000017472
Gene Symbol: SPHK2
3 Cross references
209 Possible Orthologues:

Sphingosine-1-Phosphate Receptor 1

Ensembl ID : ENSODEG00000005867
Gene Symbol: S1PR1
1 Cross references
200 Possible Orthologues:

Spleen Associated Tyrosine Kinase

Ensembl ID : ENSODEG00000000792
Gene Symbol: SYK
3 Cross references
200 Possible Orthologues:

Steroid 5 Alpha-Reductase 2

Ensembl ID : ENSODEG00000007211
Gene Symbol: SRD5A2
3 Cross references
263 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSODEG00000002760
Gene Symbol: SOAT1
1 Cross references
210 Possible Orthologues:

Sucrase-Isomaltase

Ensembl ID : ENSODEG00000001926
Gene Symbol: SI
1 Cross references
200 Possible Orthologues:

Synuclein Alpha

Ensembl ID : ENSODEG00000000377
Gene Symbol: SNCA
3 Cross references
189 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSODEG00000013525
Gene Symbol: TACR1
3 Cross references
267 Possible Orthologues:

Tachykinin Receptor 2

Ensembl ID : ENSODEG00000013359
Gene Symbol: TACR2
3 Cross references
199 Possible Orthologues:

Tachykinin Receptor 3

Ensembl ID : ENSODEG00000003150
Gene Symbol: TACR3
3 Cross references
256 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).